BSEBoard Meeting22 Jun 2026 · 22 Jun 2026, 04:56 pm
Dr Reddys Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Dr Reddys Laboratories Ltd · 500124
✦ AI Summary
Dr. Reddy's Laboratories Ltd. announced that its Board of Directors will convene on July 22, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This is a routine regulatory filing ahead of the quarterly earnings release. Concurrently, the trading window for the company's securities will remain closed from June 24, 2026, until July 24, 2026, for designated persons.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
Full Announcement
Dr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation for Considering The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On June 30, 2026